Select language:  
1800 620 420
Close menu

Clinical trials

Improving the treatment and lives of patients with blood cancer by supporting leading edge clinical trials

We are committed to supporting initiatives that improve health outcomes for blood cancer patients including improved access to new drugs that may be more effective than those currently available. One of the ways to do this is through clinical trials which are the pivotal step in a long process to prove the effectiveness and safety of potential new treatments discovered in the laboratory.

By participating in a clinical trial, patients can access potentially lifesaving treatments not currently available to them. If a clinical trial is successful, the drug can go on to become a new treatment option for patients in the wider community.

Clinical trials: FAQs

Blood Cancer Genomics Trial

The Trials Enabling Program (TEP)

New trial offers renewed hope to children and young adults with ALL

Last updated on January 30th, 2023

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.